Renal Toxicity with Sevoflurane Brenda A. GentzT. Philip Malan Jr Current Opinion 10 October 2012 Pages: 2155 - 2162
Interactions Between Herbal Medicines and Prescribed Drugs Angelo A. IzzoEdzard Ernst Review Article 10 October 2012 Pages: 2163 - 2175
Treatment Options in Hormone-Refractory Prostate Cancer Katherine A. HarrisDavid M. Reese Review Article 10 October 2012 Pages: 2177 - 2192
Pharmacological Options for the Treatment of Tourette’s Disorder Félix Javier Jiménez-JiménezPedro José García-Ruiz Therapy in Practice 10 October 2012 Pages: 2207 - 2220
Once-Weekly Fluoxetine Antona J. WagstaffKaren L. Goa Adis New Formulation Profile 10 October 2012 Pages: 2221 - 2228
Once-Weekly Fluoxetine William J. Burke Adis New Formulation Profile 10 October 2012 Pages: 2229 - 2229
Once-Weekly Fluoxetine Alexander NeumeisterW. Wolfgang Fleischhacker Adis New Formulation Profile 10 October 2012 Pages: 2229 - 2230
Cetirizine/Pseudoephedrine Keri WellingtonBlair Jarvis Adis New Formulation Profile 10 October 2012 Pages: 2231 - 2240
Cetirizine/Pseudoephedrine Friedrich Horak Adis New Formulation Profile 10 October 2012 Pages: 2241 - 2241
Cetirizine/Pseudoephedrine K. Kontou-Fili Adis New Formulation Profile 10 October 2012 Pages: 2241 - 2241
Estradiol-Intranasal Mukta DooleyCaroline M. SpencerDouglas Ormrod Adis Drug Evaluation 10 October 2012 Pages: 2243 - 2262
Peginterferon-α-2a (40kD) Caroline M. PerryBlair Jarvis Adis Drug Evaluation 10 October 2012 Pages: 2263 - 2288
Transdermal Fentanyl Richard B. R. MuijsersAntona J. Wagstaff Adis Drug Evaluation 10 October 2012 Pages: 2289 - 2307
Rabeprazole Christopher I. CarswellKaren L. Goa Adis Drug Evaluation 10 October 2012 Pages: 2327 - 2356